Spectral AI, Inc. (MDAI) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of Spectral AI, Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDAI
Spectral AI, Inc.
$1.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PDSB
PDS Biotechnology Corporation
$1.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MDAI vs PDSB
growth of $100 · dividends reinvested · last 5yMDAI -82.6% (-29.5%/yr)PDSB -74.2% (-23.8%/yr)PDSB compounded faster over this window
MDAI PDSB
MDAI vs PDSB: by the numbers
- •PDSB is the larger company ($58M vs $53M market cap).
- •Both run net losses; PDSB's is the smaller (0.00% vs -69.27% net margin).
Metrics side by side
Valuation
| Metric | MDAI | PDSB |
|---|---|---|
| P/S ratio | 3.49 | N/A |
Profitability
| Metric | MDAI | PDSB |
|---|---|---|
| Gross margin | 41.51% | 0.00% |
| Operating margin | -43.78% | 0.00% |
| Net margin | -69.27% | 0.00% |
| ROIC | -353.68% | -3699.99% |
Growth (annualized)
| Metric | MDAI | PDSB |
|---|---|---|
| Total return CAGR (5Y) | -29.57% | -39.13% |
Frequently asked
- How have MDAI and PDSB total returns compared?
- Over the past 5 years, MDAI delivered -29.57% and PDSB delivered -39.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.